Table 2. Comparison of demographic and co-morbidities between rebleed and no rebleed groups.

NSAID, non-steroidal anti-inflammatory drugs; CAD, coronary artery disease; DM, diabetes mellitus; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; SD, standard deviation.

Characteristic	All patients (n=480)	Rebleed group (n=14)	Non Rebleed group (n=466)	P-value
Age (Mean ±SD)	40.9 ± 15.9	38.4±19.8	40.9 ± 15.8	0.56
Male Sex, n (%)	406 (85%)	14 (100%)	392 (84%)	0.1
Urban domicile, n (%)	119 (25%)	4 (29%)	115 (25%)	0.74
Smokers	95(19.8%)	3(21.4%)	92(19.7%)	0.8
Mean No. of Cigarettes Per Day ± SD	8.6 ± 3.6	16.7  ± 11.5	8.3 ± 2.9	0.000 (R= 0.41)
Alcohol  intake	8(1.7%)	1(7.1%)	7(1.5 %)	0.2
NSAID	50(10.4%)	0(0%)	50 (10.7 %)	0.21
Antiplatelets	14(2.9 %)	0(0%)	14(3%)	0.65
Anticoagulants	1(0.2%)	0(0%)	1 (0.2%)	0.97
All Co morbidities	52(10.8%)	2(14.3%)	50(10.7%)	0.67
Mean No. of Comorbidities SD	1.7 ± 0.8	2±0	1.6±0.8	0.5
Hypertension	40 (8.3%)	1(7%)	39 (8.4 %)	0.67
CAD	12(2.5 %)	0(0%)	12(2.6%)	0.69
Malignancy	3(0.62%)	0(0%)	3 (0.6%)	0.91
DM	16(3.3%)	2(14%)	14(3%)	0.12*
CKD	5(1.0%)	1(7%)	4(0.8%)	0.34**
Stroke	3(0.6%)	0(%)	3(0.6%)	0.91
COPD	4(0.8%)	0(0%)	4(0.8%)	0.88